RFS. (A-F) RFS curves are shown for all patients, stratified by MRD status at TP1 and TP2 (A); ELN intermediate or adverse risk, stratified by MRD status at TP1 and TP2 (B); non-SCT recipients, stratified by MRD status at TP1 and TP2 (C); SCT recipients, stratified by MRD status at TP1 and TP2 (D); landmark analysis of RFS in MRD Neg/Neg patients, stratified by SCT in CR1 (E); and landmark analysis of RFS in ELN intermediate-risk patients who were MRD Neg/Neg, stratified by SCT in CR1 (F).